According to a new report published by Allied Market Research, titled, “Synthetic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021-2030” Synthetic drug is pharmaceutical medication created through man made engineering in contrast to natural ingredients. They are also known as new psychoactive substances (NSPs) and aim at mimicking the effects of illegal drugs including cannabis and cocaine. Major types of synthetic drugs include synthetic cannabinoids, piperazines, and synthetic cathinones. Few of the side effects associated with intake of synthetic drugs include dry mouth, euphoria, increased appetite, and feeling of wellbeing.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐨𝐮𝐜𝐡𝐞𝐫: https://www.alliedmarketresearch.com/request-sample/13752
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global synthetic drugs market.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/13752
Regions such as the Middle East and Asia-Pacific are anticipated to witness gradual growth in synthetic drug market owing to growing demand for new age therapeutics combined with rising consumer disposable income and the will to spend more for better healthcare facilities.
Introduction of techniques like biosynthesis over conventional techniques are further helping in enhancing growth of synthetic drug market. In 2019, Renew Biopharma has recently announced a landmark patent related to enzyme engineering for production of cannabinoids using biosynthesis.
- This study presents the analytical depiction of the synthetic drugs industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the synthetic drugs market share.
- The current market is quantitatively analyzed from 2020 to 2030 to highlight the synthetic drugs growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧: https://www.alliedmarketresearch.com/request-for-customization/13752
Key Market Players
- Mylan N.V.
- Lygos Inc.
- Hyasynth Biologicals, Inc.
- Alkem Labs
- Renew Biopharma
- KBL Merger Corp. IV
- Ginkgo Bioworks
- Emerald Health Pharmaceuticals
- CB Therapeutics, Inc.
- Insys Therapeutics, Inc.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
North America and Europe Menstrual Cup Market: https://www.alliedmarketresearch.com/north-america-and-europe-menstrual-cup-market-A06126
Surgical Robotic System Market: https://www.alliedmarketresearch.com/surgical-robotic-systems-market-A06827
Surgical Drains Market: https://www.alliedmarketresearch.com/wound-drainage-surgical-drains-market-A07517
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
5933 NE Win Sivers Drive
205, Portland, OR 97220
Toll Free: 1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060